Dolichol-phosphate mannosyltransferase subunit 3 (DPM3) plays a crucial role in the biosynthesis of glycoproteins. It is a component of the enzyme complex that catalyzes the addition of mannose from GDP-mannose to dolichol phosphate, a pivotal step in the formation of the lipid-linked oligosaccharide precursor for N-linked glycosylation. This glycosylation process is essential for proper folding, stability, and function of many proteins. The regulation of DPM3 expression is a finely tuned process, as it is integral to maintaining the efficiency and fidelity of protein glycosylation. An understanding of the factors that can upregulate the expression of DPM3 is important in the context of cellular biology and biochemistry, particularly in the study of glycoprotein synthesis and function.
Research has identified various chemical compounds that can potentially serve as activators to increase the expression of DPM3. For instance, retinoic acid, a metabolite of vitamin A, has been shown to interact with its nuclear receptors to promote the transcription of genes, which can include those involved in the glycosylation pathways such as DPM3. Similarly, compounds like 5-Azacytidine work at the epigenetic level, potentially reducing methylation at the promoter regions of genes, thereby encouraging their expression. Histone deacetylase inhibitors, such as Trichostatin A and Sodium butyrate, can alter chromatin structure, leading to a more transcriptionally active state that may enhance the expression of DPM3. Additionally, signaling molecules like Forskolin, which elevate intracellular cAMP levels, can activate transcription factors involved in the expression of a wide range of genes, possibly encompassing those encoding glycosylation enzymes. It is through the intricate interplay of such chemical signals and cellular mechanisms that the expression of DPM3 is dynamically modulated within the cell.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid, through its interaction with retinoic acid receptors, may upregulate the transcription of genes including those in the glycosylation pathway, potentially DPM3. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine could stimulate the transcription of DPM3 by promoting the demethylation of its promoter region. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A, as a histone deacetylase inhibitor, could lead to enhanced acetylation of histones associated with the DPM3 gene, thereby stimulating its transcription. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin may increase DPM3 expression through the activation of the cAMP pathway, which subsequently activates CREB, a transcription factor that could target the DPM3 gene. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate could increase the transcription of DPM3 by inhibiting histone deacetylases, leading to a more open chromatin structure at the DPM3 locus. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can stimulate the expression of genes controlling cellular responses to GSK-3 inhibition, which might include the upregulation of the DPM3 gene. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin may induce a compensatory increase in DPM3 expression as a response to its inhibition of N-linked glycosylation, which is part of the process DPM3 is involved in. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin can trigger a cellular stress response that may include the upregulation of DPM3 as part of the unfolded protein response to disrupted calcium homeostasis. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
β-Estradiol could upregulate DPM3 expression by engaging estrogen receptors, which can promote the expression of genes involved in the glycosylation process. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $107.00 | 3 | |
Spironolactone, through antagonism of aldosterone receptors, may lead to the upregulation of DPM3 gene expression as part of its influence on electrolyte and fluid balance. | ||||||